@article{4e5eedae9e9043cf8765cf016cc414b1,
title = "Associations of Hemoglobin A1c With Cardiovascular Disease and Mortality in Chinese Adults With Diabetes",
author = "Jieli Lu and Weiqing Wang and Mian Li and Yufang Bi and Yu Xu and Lulu Chen and Jiajun Zhao and Yiming Mu and DeFronzo, {Ralph A.} and Guang Ning",
note = "Funding Information: Please note: Research reported in this publication was supported by the National Basic Research Program of China (973 Program) under award 2015CB553601; the Ministry of Science and Technology of China under awards 2016YFC1305600, 2016YFC1305202, 2016YFC1304904, 2016YFC0901200, and 2017YFC1310700; and Shanghai Three-Year Action Plan on Public Health under award 15GWZK0802. Dr. DeFronzo is on the advisory board of AstraZeneca, Novo Nordisk, Janssen, Boehringer Ingelheim, Intarcia, and Elcelyx; has received research support from Boehringer Ingelheim, Takeda, AstraZeneca, and Janssen; and is on the Speakers Bureau of Novo-Nordisk, AstraZeneca, and Merck. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. ",
year = "2018",
month = dec,
day = "18",
doi = "10.1016/j.jacc.2018.09.062",
language = "English (US)",
volume = "72",
pages = "3224--3225",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "24",
}